These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. Kettenbach J, Köstler W, Rücklinger E, Gustorff B, Hüpfl M, Wolf F, Peer K, Weigner M, Lammer J, Müller W, Goldberg SN. AJR Am J Roentgenol; 2003 Jun; 180(6):1537-45. PubMed ID: 12760914 [Abstract] [Full Text] [Related]
3. [Ultrasound-guided assistant infusion technique for percutaneous radiofrequency ablation of liver cancer]. Han Y, Hao YZ, Cai JQ, Yang M, Liu S, He LF, Yu L, Chen MH. Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):266-9. PubMed ID: 22964146 [Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus? Giorgio A, Di Sarno A, de Stefano G, Farella N, Scognamiglio U, de Stefano M, Giorgio V. AJR Am J Roentgenol; 2009 Oct; 193(4):948-54. PubMed ID: 19770315 [Abstract] [Full Text] [Related]